Influenza update: a review of currently available vaccines.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  P & T : a peer-reviewed journal for formulary management

• Publication date

  2011-10-01

• Fields of study

  Medicine

• Identifiers
  PMID 22346299PMCID PMC3278149
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dose-Sparing H5N1 A/Indonesia/05/2005 Pre-pandemic Influenza Vaccine in Adults and Elderly Adults: A Phase III, Placebo-Controlled, Randomized Study

  2011cited by this paper
• Deaths: preliminary data for 2009.

  2011cited by this paper
• Immunogenicity of a monovalent 2009 influenza A(H1N1) vaccine in infants and children: a randomized trial.

  2010cited by this paper
• Safety and cross-reactive immunogenicity of candidate AS03-adjuvanted prepandemic H5N1 influenza vaccines: a randomized controlled phase 1/2 trial in adults.

  2010cited by this paper
• Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010.

  2010cited by this paper
• Influenza vaccines for the future.

  2010cited by this paper
• Estimates of deaths associated with seasonal influenza --- United States, 1976-2007.

  2010cited by this paper
• Immunogenicity and safety of intradermal influenza vaccination in healthy older adults.

  2010cited by this paper
• Immunogenicity, large scale safety and lot consistency of an intradermal influenza vaccine in adults aged 18–60 years: Randomized, controlled, Phase III trial

  2010cited by this paper
• Novel swine-origin influenza virus A (H1N1): the first pandemic of the 21st century.

  2009cited by this paper
• Influenza control in the 21st century: Optimizing protection of older adults.

  2009cited by this paper
• The persistent legacy of the 1918 influenza virus.

  2009cited by this paper
• Randomized, double-blind controlled phase 3 trial comparing the immunogenicity of high-dose and standard-dose influenza vaccine in adults 65 years of age and older.

  2009cited by this paper
• Antigenic and Genetic Characteristics of Swine-Origin 2009 A(H1N1) Influenza Viruses Circulating in Humans

  2009cited by this paper
• Single dose vaccination with AS03-adjuvanted H5N1 vaccines in a randomized trial induces strong and broad immune responsiveness to booster vaccination in adults.

  2009cited by this paper
• Better influenza vaccines for older people: what will it take?

  2008cited by this paper
• Seasonal influenza vaccine delivered by intradermal microinjection: A randomised controlled safety and immunogenicity trial in adults.

  2008cited by this paper
• Intradermal influenza vaccine administered using a new microinjection system produces superior immunogenicity in elderly adults: a randomized controlled trial.

  2008cited by this paper
• Rectification of Age-Associated Deficiency in Cytotoxic T Cell Response to Influenza A Virus by Immunization with Immune Complexes

  2007cited by this paper
• Impact of influenza vaccination on major cause-specific mortality.

  2007cited by this paper
• Challenges for vaccination in the elderly

  2007cited by this paper
• The annual impact of seasonal influenza in the US: measuring disease burden and costs.

  2007cited by this paper
• Safety and immunogenicity of a high dosage trivalent influenza vaccine among elderly subjects.

  2007cited by this paper
• Safety of high doses of influenza vaccine and effect on antibody responses in elderly persons.

  2006cited by this paper
• Vaccines for seasonal and pandemic influenza.

  2006cited by this paper
• Antibody response to influenza vaccination in the elderly: a quantitative review.

  2006cited by this paper
• A review of vaccine research and development: Human acute respiratory infections

  2005cited by this paper
• Influenza-associated hospitalizations in the United States.

  2004cited by this paper
• Immunogenicity and protective efficacy of influenza vaccination.

  2004cited by this paper
• Prevention and early treatment of influenza in healthy adults.

  2000cited by this paper
• Humoral Immune Response to Influenza Vaccination in Patients from High Risk Groups

  2000cited by this paper
• The impact of influenza epidemics on hospitalizations.

  2000cited by this paper
• The socio-economic burden of influenza.

  1999cited by this paper
• Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens.

  1998cited by this paper
• Pandemic versus epidemic influenza mortality: a pattern of changing age distribution.

  1998cited by this paper
• The impact of influenza and influenza-like illness on productivity and healthcare resource utilization in a working population.

  1998cited by this paper
• Measuring protection: efficacy versus effectiveness.

  1998cited by this paper
• The impact of influenza epidemics on mortality: introducing a severity index.

  1997cited by this paper
• The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial.

  1994cited by this paper
• Serum and nasal wash antibodies associated with resistance to experimental challenge with influenza A wild-type virus

  1986cited by this paper
• A one-year study of trivalent influenza vaccines in primed and unprimed volunteers: immunogenicity, clinical reactions and protection

  1984cited by this paper
• Immunity to influenza in man.

  1983cited by this paper
• Influenza vaccination of elderly persons. Reduction in pneumonia and influenza hospitalizations and deaths.

  1980cited by this paper
• Field trial with human and equine influenza vaccines in children: protection and antibody titres.

  1972cited by this paper
• The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses

  1972cited by this paper

• Interplay between viral infections and gut microbiota dysbiosis: Mechanisms and therapeutic potential

  2026cites this paper
• Hypoxia-inducible factor-1α exacerbates immune injury induced by influenza A virus and Streptococcus pneumoniae coinfection

  2025cites this paper
• Single-cell RNA-seq reveals the immune response of Co-infection with streptococcus pneumoniae after influenza A virus by a lung-on-chip: The molecular structure and mechanism of tight junction protein ZO-1.

  2025cites this paper
• hMPV co-infections: Distinct immunopathogenic mechanisms and clinical implications of viral and bacterial pathogenesis

  2025cites this paper
• Anti-Influenza Activity of 6BIGOE: Improved Pharmacological Profile After Encapsulation in PLGA Nanoparticles

  2025cites this paper
• Acute effects of air pollutants on influenza-like illness in Hangzhou, China

  2025influential citation
• Advancing influenza virus treatment: in vitro and ex vivo studies of PI3K inhibitor-loaded lipid nanoparticles

  2025cites this paper
• Cytokine Storm Related to CD4+ T Cells in Influenza Virus-Associated Acute Necrotizing Encephalopathy

  2024cites this paper
• GRP78 exerts antiviral function against influenza A virus infection by activating the IFN/JAK-STAT signaling.

  2024cites this paper
• Influenza and the gut microbiota: A hidden therapeutic link

  2024cites this paper
• Impaired influenza A virus replication by the host restriction factor SAMHD1 which inhibited by PA-mediated dephosphorylation of the host transcription factor IRF3

  2024cites this paper
• MC-NN: An End-to-End Multi-Channel Neural Network Approach for Predicting Influenza A Virus Hosts and Antigenic Types

  2023cites this paper
• Hypoxia Induces Alterations in the Circadian Rhythm in Patients with Chronic Respiratory Diseases

  2023cites this paper
• A Systematic Review of Clinical Pharmacokinetics of Inhaled Antiviral

  2023cites this paper
• Broccoli Leaves Attenuate Influenza A Virus Infection by Interfering With Hemagglutinin and Inhibiting Viral Attachment

  2022cites this paper
• In silico epitope-based vaccine design against influenza a neuraminidase protein: Computational analysis established on B- and T-cell epitope predictions

  2022influential citation
• Sleep Apnea and Risk of Influenza-Associated Severe Acute Respiratory Infection: Real-World Evidence

  2022cites this paper
• Comparing Influenza Virus Biology for Understanding Influenza D Virus

  2022cites this paper
• Multi-channel neural networks for predicting influenza A virus hosts and antigenic types

  2022influential citation
• An epitope-optimized human H3N2 influenza vaccine induces broadly protective immunity in mice and ferrets

  2022cites this paper
• Detection of respiratory viruses directly from clinical samples using next‐generation sequencing: A literature review of recent advances and potential for routine clinical use

  2022cites this paper
• Epipharyngeal Abrasive Therapy Down-regulates the Expression of Cav1.2: A Key Molecule in Influenza Virus Entry

  2022cites this paper
• Predictors of Influenza Vaccination among Chinese Middle School Students Based on the Health Belief Model: A Mixed-Methods Study

  2022cites this paper
• End-to-End Multi-channel Neural Networks for Predicting Influenza a Virus Hosts and Antigenic Types

  2022influential citation
• Estimation of Reduction in Influenza Vaccine Effectiveness Due to Egg-Adaptation Changes—Systematic Literature Review and Expert Consensus

  2021cites this paper
• A Herbal Mixture Formula of OCD20015-V009 Prophylactic Administration to Enhance Interferon-Mediated Antiviral Activity Against Influenza A Virus

  2021cites this paper
• Human Properdin Released By Infiltrating Neutrophils Can Modulate Influenza A Virus Infection

  2021cites this paper
• NetworkSIR and EnvironmentalSIR: Effective, Open-Source Epidemic Modeling in the Absence of Data

  2021cites this paper
• Adjuvantation of Influenza Vaccines to Induce Cross-Protective Immunity

  2021cites this paper
• Social media effectiveness as a humanitarian response to mitigate influenza epidemic and COVID-19 pandemic

  2021cites this paper
• A brief review of influenza virus infection

  2021cites this paper
• COVID-19 Impact on Medical Practice in Sub-Saharan Africa; The Need to Guard Against Medical Negligence: A Case Report in a Health Care Facility in Kumasi, Ghana

  2021cites this paper
• Quali/quantitative research on herbal supplements containing black elder (Sambucus nigra L.) fruits

  2021influential citation
• Interplay between hypoxia and inflammation contributes to the progression and severity of respiratory viral diseases

  2021cites this paper
• COVID-19 and the flu: data simulations and computational modelling to guide public health strategies

  2021cites this paper
• COVID-19 pandemic impact on seasonal flu vaccination: A cross-sectional study

  2021cites this paper
• Assessment of the Feasibility of Using Noninvasive Wearable Biometric Monitoring Sensors to Detect Influenza and the Common Cold Before Symptom Onset

  2021cites this paper
• TCRM_A_272908 1007..1022

  2020cites this paper
• The potential environmental role of fungi as a complication in COVID-19 infections

  2020cites this paper
• Combating COVID-19: A Coordinated Efforts of Healthcare Providers and Policy Makers with Global Participation Are Needed to Achieve the Desired Goals

  2020cites this paper
• Influenza-Induced Oxidative Stress Sensitizes Lung Cells to Bacterial-Toxin-Mediated Necroptosis

  2020cites this paper
• Estimation of Reproduction Number of Influenza in Greece using SIR Model

  2020cites this paper
• Covid-19 in Deutschland – Erklärung, Prognose und Einfluss gesundheitspolitischer Maßnahmen

  2020cites this paper
• COVID-19 and importance of environmental sustainability

  2020cites this paper
• COVID‐19 and rationally layered social distancing

  2020cites this paper
• Dangerous Pathogens as a Potential Problem for Public Health

  2020cites this paper
• The Double Burden of the COVID-19 Pandemic and Polypharmacy on Geriatric Population – Public Health Implications

  2020cites this paper
• Immunopathogenesis of SARS-CoV-2-induced pneumonia: lessons from influenza virus infection

  2020cites this paper
• The Kinetics Of Influenza A (A/CALIFORNIA/4/2009-H1N1) And B (B/PHUKET/3073/2013 (BYAM), B/BRISBANE/60/2008 (BVIC)) Virus Infection In Ferrets

  2020cites this paper
• The Cytokine Storm and Pre-Cytokine Storm Status in COVID-19-A Model for Managing Population Risk for Pandemics and Chronic Diseases

  2020cites this paper
• Outcomes of patients with definitive diagnosis of influenza a (H1N1) virus infection admitted to affiliated hospitals of Babol University of Medical Sciences, 2015-2016

  2019cites this paper
• Fluzone® intra-dermal (Intanza®/Istivac® Intra-dermal): An updated overview

  2016cites this paper
• Structure et dynamique du peptide de fusion membranaire du virus Influenza et son impact sur la membrane

  2014cites this paper
• Adenovirus-Based Vectors for the Development of Prophylactic and Therapeutic Vaccines

  2014cites this paper
• Advances and Future Challenges in Recombinant Adenoviral Vectored H5N1 Influenza Vaccines

  2012cites this paper
• World Journal of Hepatology

  year unknowncites this paper
• World Journal of Hepatology

  year unknowncites this paper